Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
August 20, 2025Diabetes Obesity and Metabolism

Cardiovascular disease risk estimates for primary prevention in the US prediabetes and diabetes population using the PREVENT equation

View Full Paper
Ask AI
Bookmark
Share

Authors

XLXunliang LiWZWenman ZhaoZLZhao Li

Discussion

Loading...

Member takes

Overview

Comparison of CVD risk estimates and statin eligibility in diabetes and prediabetes using PREVENT equations suggests important implications.

Key Points

  • The PREVENT equations estimate lower ASCVD risk compared to Pooled Cohort Equations in diabetes and prediabetes populations.
  • In individuals with diabetes, the 10-year ASCVD risk was estimated at 8.0% using PREVENT against 15.7% with PCEs.
  • This observational analysis used NHANES data, representing a significant portion of US adults aged 40-75 without known CVD.
  • These findings may impact how preventive strategies are tailored, particularly regarding statin eligibility for high-risk groups.

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/68af3e34cf1dd9ea359eac67https://doi.org/10.1111/dom.70043
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1PREVENT and PCE Models for Estimating ASCVD Risk Stratified by Statin Exposure2025 · 6 citations
  2. 2Predicting risk of cardiovascular events (PREVENT) score accuracy among people with HIV in the multicenter CNICS cohort2025
  3. 3Validation of the American Heart Association Predicting Risk of Cardiovascular Disease Events Equations in Diverse Socioeconomic Groups: The All of Us Cohort2025
  4. 4Comparison of Short‐ and Long‐Term Cardiovascular Disease Risk Assessment Tools in US Young Adults2025 · 2 citations
  5. 5Prognostic Value of the American Heart Association PREVENT Cardiovascular Disease Risk Equations in Cancer Survivorship: A NHANES Population‐Based Study (2009–2018)2025